- Home
- INCR vs DTF Comparison
INCR vs DTF Comparison
Compare INCR & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INCR | DTF |
|---|---|---|
| Founded | 1994 | 1991 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.3M | 79.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | INCR | DTF |
|---|---|---|
| Price | $1.18 | $11.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 46.0K | 21.1K |
| Earning Date | 10-08-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | ★ $72,158,312.00 | N/A |
| Revenue This Year | $69.54 | N/A |
| Revenue Next Year | $41.75 | N/A |
| P/E Ratio | ★ N/A | $24.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.22 | $10.29 |
| 52 Week High | $1.79 | $11.19 |
Technical Indicators
Market Signals| Indicator | INCR | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 37.69 | 47.76 |
| Support Level | $1.35 | $11.33 |
| Resistance Level | $1.51 | $11.37 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 13.90 | 25.02 |
Price Performance
Historical ComparisonAbout INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.